Mito-apocynin (C2) (C007B-375370)

Mito-apocynin (C2), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP + cation. Mito-apocynin (C2) exhibits antineuroinflammatory effect.In VivoMito-apocynin (C2) (3 mg/kg; p.o.; daily for 12 days) exhibits antineuroinflammatory effect . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: MPTP mice model of Parkinson’s Disease Dosage: 3 mg/kg Administration: Oral gavage; daily for 12 days Result: Significantly attenuated MPTP-induced glial cell activation, proinflammatory cytokine upregulation, inducible nitric oxide synthase, and NOX2 components (gp91phox).Form:Solid. Specification: 0.98 Molecular Formula: C28H27BrNO3P Molecular Weight: 536.4

UPC:

51281822

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

M651779-50mg

CAS:

1254044-41-1

Product Size:

50mg